By the comparison of KLK7 expression in four data sets, meta-analysis demonstrated that KLK7 was significantly increased in two types of ovarian cancer, namely, ovarian serous adenocarcinoma and ovarian endometrioid adenocarcinoma (Figure 2e). Here, KLK7 is linked to ovarian carcinoma.